Literature DB >> 9155573

Efficacy of primed infusions with high dose ranitidine and omeprazole to maintain high intragastric pH in patients with peptic ulcer bleeding: a prospective randomised controlled study.

J Labenz1, U Peitz, C Leusing, B Tillenburg, A L Blum, G Börsch.   

Abstract

BACKGROUND: In healthy subjects, continuous infusions of high dose ranitidine and omeprazole produce high intragastric pH values. AIM: To test the hypothesis that both drugs also maintain high intragastric pH values in patients with bleeding ulcers. PATIENTS AND METHODS: In two parallel studies, 20 patients with bleeding duodenal ulcers and 20 patients with bleeding gastric ulcers were randomly assigned to receive either ranitidine (0.25 mg/kg/hour after a bolus of 50 mg) or omeprazole (8 mg/hour after a bolus of 80 mg) for 24 hours. Intragastric pH was continuously recorded with a glass electrode placed 5 cm below the cardia.
RESULTS: Both drugs rapidly raised the intragastric pH above 6. During the second 12 hour period, however, the percentage of time spent below a pH of 6 was 0.15% with omeprazole and 20.1% with ranitidine (p = 0.0015) in patients with duodenal ulcer; in patients with gastric ulcer it was 0.1% with omeprazole and 46.1% with ranitidine (p = 0.002).
CONCLUSIONS: Primed infusions of omeprazole after a bolus produced consistently high intragastric pH values in patients with bleeding peptic ulcers, whereas primed infusions with ranitidine were less effective during the second half of a 24 hour treatment course. This loss of effectiveness may be due to tolerance.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9155573      PMCID: PMC1027005          DOI: 10.1136/gut.40.1.36

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  45 in total

1.  Mucus degradation by pepsin: comparison of mucolytic activity of human pepsin 1 and pepsin 3: implications in peptic ulceration.

Authors:  J P Pearson; R Ward; A Allen; N B Roberts; W H Taylor
Journal:  Gut       Date:  1986-03       Impact factor: 23.059

2.  Continuous intravenous infusions of famotidine maintain high intragastric pH in duodenal ulcer.

Authors:  H S Merki; L Witzel; D Kaufman; M Kempf; J Neumann; J Röhmel; R P Walt
Journal:  Gut       Date:  1988-04       Impact factor: 23.059

3.  Clot lysis by gastric juice: an in vitro study.

Authors:  S E Patchett; H Enright; N Afdhal; W O'Connell; D P O'Donoghue
Journal:  Gut       Date:  1989-12       Impact factor: 23.059

4.  Pharmacodynamics of intravenous ranitidine after bolus and continuous infusion in patients with healed duodenal ulcers.

Authors:  S W Sanders; K N Buchi; J G Moore; A L Bishop
Journal:  Clin Pharmacol Ther       Date:  1989-11       Impact factor: 6.875

5.  Circadian rhythm of gastric acid secretion in men with active duodenal ulcer.

Authors:  J G Moore; F Halberg
Journal:  Dig Dis Sci       Date:  1986-11       Impact factor: 3.199

6.  Intravenous omeprazole: effect on 24-hour intragastric pH in duodenal ulcer patients.

Authors:  T Lind; M Moore; L Olbe
Journal:  Digestion       Date:  1986       Impact factor: 3.216

7.  Non-bleeding visible vessel treatment: perendoscopic injection therapy versus omeprazole infusion.

Authors:  C Grosso; A Rossi; P Gambitta; M Bini; G Zanasi; Z Pirone; R Arcidiacono
Journal:  Scand J Gastroenterol       Date:  1995-09       Impact factor: 2.423

Review 8.  Omeprazole: pharmacokinetics and metabolism in man.

Authors:  C Cederberg; T Andersson; I Skånberg
Journal:  Scand J Gastroenterol Suppl       Date:  1989

9.  Effect of curing Helicobacter pylori infection on intragastric pH during treatment with omeprazole.

Authors:  E F Verdú; D Armstrong; J P Idström; J Labenz; M Stolte; G Dorta; G Börsch; A L Blum
Journal:  Gut       Date:  1995-12       Impact factor: 23.059

10.  Intravenous omeprazole rapidly raises intragastric pH.

Authors:  R P Walt; J R Reynolds; M J Langman; H L Smart; G Kitchingman; K W Somerville; C J Hawkey
Journal:  Gut       Date:  1985-09       Impact factor: 23.059

View more
  16 in total

1.  Ulcers: adjuvant PPIs to prevent major ulcer bleeds.

Authors:  Andreas Leodolter; Joachim Labenz
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-08       Impact factor: 46.802

2.  Some Observations on PPI Therapy for Bleeding Ulcer.

Authors:  Grigoris I Leontiadis; Colin W Howden
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-08

Review 3.  Appropriate use of intravenous proton pump inhibitors in the management of bleeding peptic ulcer.

Authors:  Venodhar R Julapalli; David Y Graham
Journal:  Dig Dis Sci       Date:  2005-07       Impact factor: 3.199

4.  How evidence-based are current guidelines for managing patients with peptic ulcer bleeding?

Authors:  Angelo Andriulli; Antonio Merla; Fabrizio Bossa; Marco Gentile; Giuseppe Biscaglia; Nazario Caruso
Journal:  World J Gastrointest Surg       Date:  2010-01-27

5.  Intravenous proton pump inhibitors for peptic ulcer bleeding: Clinical benefits and limits.

Authors:  Hsiu-Chi Cheng; Bor-Shyang Sheu
Journal:  World J Gastrointest Endosc       Date:  2011-03-16

Review 6.  Systematic review and meta-analysis of proton pump inhibitor therapy in peptic ulcer bleeding.

Authors:  Grigoris I Leontiadis; Virender K Sharma; Colin W Howden
Journal:  BMJ       Date:  2005-01-31

7.  Intravenous pantoprazole versus ranitidine for prevention of rebleeding after endoscopic hemostasis of bleeding peptic ulcers.

Authors:  Ping-I Hsu; Gin-Ho Lo; Ching-Chu Lo; Chiun-Ku Lin; Hoi-Hung Chan; Chung-Jen Wu; Chang-Bih Shie; Pei-Min Tsai; Deng-Chyang Wu; Wen-Ming Wang; Kwok-Hung Lai
Journal:  World J Gastroenterol       Date:  2004-12-15       Impact factor: 5.742

Review 8.  Gastric acid inhibition in the treatment of peptic ulcer hemorrhage.

Authors:  Kevin A Ghassemi; Thomas O G Kovacs; Dennis M Jensen
Journal:  Curr Gastroenterol Rep       Date:  2009-12

9.  Pharmacologic treatment of peptic ulcer bleeding.

Authors:  Grigoris I Leontiadis; Colin W Howden
Journal:  Curr Treat Options Gastroenterol       Date:  2007-04

Review 10.  The short-term medical management of non-variceal upper gastrointestinal bleeding.

Authors:  Thomas O G Kovacs; Dennis M Jensen
Journal:  Drugs       Date:  2008       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.